CLINICAL TRIALS PROFILE FOR ESTRADIOL VALERATE
✉ Email this page to a colleague
All Clinical Trials for ESTRADIOL VALERATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00293059 ↗ | Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding | Completed | Bayer | Phase 3 | 2005-12-01 | The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding. |
NCT00307801 ↗ | Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding | Completed | Bayer | Phase 3 | 2006-02-01 | The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding. |
NCT00335218 ↗ | Fat Distribution in Healthy Early Postmenopausal Women | Completed | Bayer | Phase 4 | 2002-07-01 | The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ESTRADIOL VALERATE
Condition Name
Clinical Trial Locations for ESTRADIOL VALERATE
Trials by Country
Clinical Trial Progress for ESTRADIOL VALERATE
Clinical Trial Phase
Clinical Trial Sponsors for ESTRADIOL VALERATE
Sponsor Name